HSDT

Investor Moves

Name	Value	Action	Change	Price	Last Price
Ken GriffinCitadel Advisors $154k89.1k shares TrimQ1 2026 $1M $1.73 $1.67
Ken GriffinCitadel Advisors $-9.5M TrimQ4 2025 $10M -- $1.67

News

globenewswire.comSolana Company Board Unanimously Rejects Unsolicited Forward Industries Proposalglobenewswire.comJun 16

globenewswire.comUPDATED: Forward Industries Announces Letter of Intent to Acquire Solana Company (HSDT)globenewswire.comJun 15

globenewswire.comForward Industries Announces Letter of Intent to Acquire Solana Company (HSDT)globenewswire.comJun 15

seekingalpha.comSolana Company (HSDT) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 15

globenewswire.comSolana Company Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 15

Trade HSDT

About Solana Company

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

CEO: Dane Carl Andreeff
IPO Date: Jun 27, 2014

Market Data

Open: $1.37
High: $1.38
Low: $1.19
Volume: 1.2M
52W High: $92.50
52W Low: $1.19

Valuation

Market Cap: $74.2M
Enterprise Value: $69.8M

Financials

Free Cash Flow: -$61.3M
Revenue: $6M
Net Income: -$40.9M
Cash: $7.3M
Debt: $0

Events

EarningsAug 13

EPS est. -0.02